Company News

AbbVie to determine efficacy of Lopinavir and Ritonavir for treatment of COVID-19

  • Posted on: 14 March 2020
  • By: PharmaTutor News

AbbVie confirmed the company's activities in the fight to address the COVID-19 public health crisis, including supporting the experimental use of the HIV medicine, Kaletra/Aluvia (lopinavir/ritonavir) to determine its efficacy in the treatment of COVID-19.

Pharma companies received notices for introducing drugs without prior approval of the NPPA

  • Posted on: 29 July 2019
  • By: PharmaTutor News

Pharmaceutical Companies which introduced 22 drugs without prior approval of the National Pharmaceutical Pricing Authority (NPPA) have been issued notices by Government. The NPPA regularly takes action against such companies as per provisions of the Drugs (Prices Control) Order, 2013 (DPCO) which has been issued under the Essential Commodities Act, 1955.

Sanofi and Regeneron announce positive topline Phase 2 results for IL-33 antibody in asthma

  • Posted on: 22 June 2019
  • By: Shalini.Sharma

Sanofi and Regeneron Pharmaceuticals, Inc. announced that a Phase 2 proof-of-concept trial evaluating the investigational IL-33 antibody REGN3500 (SAR440340) met the primary endpoint of improvement in loss of asthma control when comparing REGN3500 monotherapy to placebo. The trial also met a key secondary endpoint, demonstrating REGN3500 monotherapy significantly improved lung function compared to placebo.